AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

Boston Scientific Reports $5.138 Billion in Q3 2026 Net Sales

First Detected: Oct 28, 2026, 10:38 AM

Last Update: 24 minutes ago

1 update

Event Summary

Boston Scientific reported net sales of $5.138 billion for the third quarter of 2026 on October 28. Sales grew by 1.5 percent on a reported, operational, and organic basis compared to the same period in the prior year. The results indicate consistent performance across all primary financial metrics for the company.

Timeline

Latest developmentabout 5 hours ago

Boston Scientific Cuts 2026 Sales Growth Outlook to 4.25% After 1.5% Quarterly Growth

Third-quarter sales topped analysts’ estimates, but adjusted earnings per share fell short and the company cut its previous full-year outlook.

Read the full story

Key facts

Boston Scientific generated net sales of $5.138 billion during the third quarter of 2026.
Sales grew 1.5 percent on a reported, operational, and organic basis compared to the prior year period.